NEW YORK (GenomeWeb) – Researchers at Children's Mercy in Kansas City have assessed the clinical utility and cost-effectiveness of exome and genome sequencing for diagnosis in a retrospective study of 119 children with neurodevelopmental disorders.
Based on their results, they suggested that trio exome and genome sequencing should be used early in the diagnostic process, rather than as a last resort, and that fast genome sequencing should be used in urgent cases.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
